AXOS FINANCIAL, INC. (AX): what the price requires

At today's price, AXOS FINANCIAL, INC. (AX) is priced for 18.8% return on equity. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high.

Generated: 2026-07-19 · Source: https://boothcheck.com/report/AX

Headline

FieldValue
TickerAX
CompanyAXOS FINANCIAL, INC.
Current price$97.61/sh
CompositionBanking Business Segment 89% / Securities Business Segment 11%

What The Price Requires (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basisfinancials
Elite ROE must persist for17.7y before normalizing (held at the 16% elite tier)
Perpetuity-equivalent ROE18.8%
Return on equity now16.1%
ROE gap+2.7pp
Price-to-book1.81x

Solve inputs: computed at a 12.2% cost of equity; ROE searched up to the 16% ROE ceiling; each 1pp moves the implied horizon ~4.8 years.

Reconcile: at the x-ray's 9.3% required return this reads ~13.5%; the models below use their own rates.

How unusual the bet is: high

ReferenceValue
vs own history+4.09σ
cohort percentile (of 119 peers)78
sustained it ~10 years at this level53%
implied end-window share0%

Valuation X-Ray

The price is supported by asset-based and earnings-power and relative-multiple and growth-DCF value. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset0.98x3justifies
Earnings0.76x2justifies
Relative0.94x3justifies
Growth1.24x1expensive

Families that justify the price: Asset, Earnings, Relative, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 10.4%); the inversion above states its own rate.

Per-Model Detail (n=9)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth——no—
Bank Fair Value (P/TBV)—$121.370.80xyesTBVPS $51.49 × 2.36x (ROE (TTM) 15.5% / CoE 9.3%, g=5.0% (sustainable: 65% retention × ROE, 5% cap; not the terminal-growth assumption), credit 1.39% allowance/loans → ×0.95)
Relative ValuationRelative$91.701.06xyesP/E 10x (static sector reference · 2026-04), scenarios: 8.3x / 10.0x / 11.7x (bear / base = reference held flat / bull), EV/EBITDA N/Ax
Simple DDMGrowth——no—
Two-Stage DDMGrowth——no—
Simple Excess ReturnAsset$90.741.08xyesBV/sh $54.04, ROE (TTM) 15.5%, ke 9.3%
Two-Stage Excess ReturnAsset$116.130.84xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$78.831.24xyesRev $1.2B, growth 9% (input: historical growth; tapered), Terminal P/S: 3.8x / 4.6x / 5.3x (bear / base = today's held flat / bull, cap 8x)
Peter Lynch Fair ValueRelative$103.800.94xyesEPS $8.20, growth 13% (input: historical EPS growth), PEG=0.92 (Undervalued)
Margin TrajectoryGrowth——no—
Earnings Power ValueEarnings——no—
Residual IncomeAsset——no—
Graham NumberAsset$99.850.98xyes√(22.5 × EPS $8.20 × BVPS $54.04) — Graham's conservative floor
EV/EBITDA RelativeRelative——no—
FCF YieldEarnings——no—
SBC-Adj FCF YieldEarnings——no—
Ben Graham FormulaEarnings$232.410.42xyesEPS $8.20 × (8.5 + 2×12.7%) × (4.4 / 5.3%)
ROIC-Justified P/BAsset——no—
P/Sales SectorRelative——no—
PEG Fair ValueRelative$155.710.63xyesEPS $8.20 × (PEG 1.5 × growth 12.7% (input: historical EPS growth)) → PE 19.0x
Earnings YieldEarnings$88.651.10xyesEPS $8.20 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelative——no—
Clinical Phase NPVGrowth——no—
MertonAsset——no—
V5 Mechanical———no—

Solvency

FieldValue
Share count CAGR (buyback)-1.2%

Deposit/float-funded balance sheet: debt is funding, not corporate leverage, and GAAP operating cash flow follows loan flows. Net-debt, interest-coverage, and cash-burn lenses do not apply. The solvency frame for a financial is regulatory capital and payout capacity (CET1, stress buffer, dividends plus buybacks against earnings).

Bullet Takeaways

Bull Case

Start with what the market is paying for and then check it against the bank's actual numbers, because here the two line up unusually well. The price trades around 1.6 times book value, a premium to the regional-bank group, and that premium is a bet that Axos keeps earning a return on equity far above its peers. The fundamentals support the bet rather than straining against it. Return on equity runs near 16%, and the engine that produces it is a net interest margin of 4.57% in the latest quarter, against net interest income that grew 11.2% year-over-year to $306.3 million; net income reached $124.7 million, or $2.15 per diluted share, up from $1.81 a year earlier. A bank earning a mid-teens return on equity with a margin near 4.6% is not an ordinary regional lender, and the premium multiple is the market recognizing that.

The structural reason the margin holds is the absence of branches. Axos gathers deposits digitally and across specialty channels rather than through an expensive physical network, which lets it fund loans more cheaply and keep more of the spread. Deposits grew 11.2% to $22.4 billion, with roughly 85% FDIC-insured or collateralized, so the funding base expanded without reaching for hot money. The asset side has been opportunistic: the FY2025 10-K describes the FDIC Loan Purchase, acquired with "a non-credit-related discount of $306.8 million and an allowance for credit losses on PCD loans of $70.1 million", the kind of distressed-seller transaction a well-capitalized bank can make when others are pulling back. Credit has stayed clean through it; the filing reports net charge-offs of "0.13%" of average loans outstanding.

Capital allocation reinforces the return story. Axos pays no dividend and retains all of its earnings, compounding book value internally, and it buys back stock: the board added $100 million to the repurchase program, and the share count has been falling about 1.2% a year. The 10-K frames the program as opportunistic, repurchasing "at times and prices considered appropriate" and weighed against "alternative uses of capital". For a bank growing book value through retained high-return earnings, that combination of internal compounding plus buybacks is the cleanest form of shareholder return, and the analyst community has moved with it: the consensus rating is positive with an average target above the current price, and Raymond James upgraded the stock to Strong Buy.

Bear Case

The bear case for Axos lives in how it deploys capital and who is on the other side of some of those decisions. This is a bank that retains every dollar of earnings, funds aggressive balance-sheet growth, and grows partly through acquisitions of distressed or specialty assets, which puts a great deal of weight on management's judgment and on governance. Aggressive growth funded entirely by retained earnings is wonderful when the loans perform and dangerous when they do not, because the same retention that compounds book value in good times leaves no dividend cushion and concentrates the downside in credit. The FDIC Loan Purchase illustrates the model: a book acquired at a $306.8 million non-credit discount with a $70.1 million allowance against purchased-credit-deteriorated loans is, by definition, a portfolio someone else wanted off their books. The bull reads that as opportunistic; the bear reads it as concentrated credit risk that has not yet been tested through a full cycle.

The valuation bet sharpens that concern. The price requires Axos to keep earning a return on equity near 18%, above even the roughly 16% it earns today, and to keep earning it for a long time. That is the spine of the bet, and it runs against the gravity every high-return bank faces: excess returns above the cost of equity tend to fade as competitors copy the model and as the easy specialty niches fill in. If the return on equity drifts back toward the low-teens cost of equity rather than holding near the high-teens the price assumes, the premium to book compresses, and a stock at 1.6 times book has room to fall toward the group's more typical multiple. The margin is already giving a little: net interest margin slipped to 4.57% from 4.78% a year earlier, and while management attributes most of that to the FDIC-purchased loans, a compressing spread is the first place a high-return bank's advantage erodes.

The third weight is execution and integration risk layered on top of the credit. Axos has grown through deals, recently absorbing the Verdant acquisition and now awaiting the close of an OCC-approved deposit acquisition later in 2026. Each acquisition adds loans and deposits the bank did not originate itself, and each one is a place where credit assumptions or integration can go wrong. None of this is visible distress; the charge-off rate is low and capital is ample. The bear case is simply that a richly-priced bank running an above-peer return on a fast-growing, acquisition-heavy, fully-retained balance sheet is pricing in a level of clean execution that the historical base rate for sustaining excess returns rarely delivers.

Valuation

For a bank, the price reduces to one question: how long can the return on equity stay above the cost of equity. At today's level the market is paying for Axos to earn a return on equity near 18%, above the roughly 16% it earns now, and to keep earning it well beyond the point where most banks' excess returns fade. That is the bet, and it is why the stock trades around 1.6 times book value rather than near the book-value-and-change a typical regional commands. The reference points make the demand concrete: a return that far above the cost of equity, sustained that long, sits in the rarer tail of the bank cohort.

Unlike a stretched growth name, the methods here largely agree the price is supported. The asset-based lenses (book value plus the bank's profitability) land near the price, the earnings-power methods sit a touch below, and the peer-multiple lens reads it as reasonable against a regional cohort trading around 10 times earnings. This is a value or quality-supported read, not a price floating above every method on a single growth assumption. The one method that prices it as cheap, a growth-adjusted earnings frame, reflects double-digit earnings growth against a modest multiple. The tension is not that the price floats above the evidence; it is that the comfortable case depends on the above-peer return on equity persisting, which is the same durability question stated in valuation terms.

The right solvency lens for a bank is capital and credit, not cash burn, and on that frame Axos is sound. Deposits are 85% insured or collateralized, net charge-offs ran 0.13% of average loans, and the bank retains all earnings while buying back stock, which builds regulatory capital rather than depleting it. The downside is therefore not a funding event; it is multiple compression. If the return on equity fades toward the cost of equity, the premium to book unwinds, and the credit embedded in the acquired loan books is where that fade would most plausibly begin.

Catalysts

The most recent quarter showed the model still working. For Q3 fiscal 2026 (ended March 31, 2026), Axos reported net income of $124.7 million and diluted EPS of $2.15, up from $1.81 a year earlier, with net interest income up 11.2% to $306.3 million and deposits up 11.2% to $22.4 billion. Net interest margin was 4.57%, down from 4.78%, which management attributed largely to the FDIC-purchased loans rather than to core spread compression. The result was a revenue beat with a softer earnings line than some expected, which is why the print drew a mixed reaction.

Two forward items bear directly on the thesis. First, Axos Bank received OCC approval on June 8, 2026, for a previously announced deposit acquisition, expected to close later in calendar 2026, which would expand the low-cost deposit base that funds the margin. Second, the board added $100 million to the buyback authorization, extending the capital-return program already underway. On sentiment, the analyst view is constructive: a positive consensus with an average target above the current price, Needham and Keefe Bruyette both at $110 targets, and a Raymond James upgrade to Strong Buy. The item to watch through all of it is credit performance on the acquired loan books as they season, since that is where a fast-growing, acquisition-heavy bank's clean numbers would first show strain.

Peer Cohorts (Per Segment, With Filing Citations)

Banking Business Segment (reported)

Securities Business Segment (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

AX Q3 FY2026 earnings release · AX board authorization, 2026 · analyst notes, 2026 · AX press releases, June 2026 · AX press release, June 2026

View the full interactive AX report on boothcheck